Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children

ABBOTT PARK, Ill., Sept. 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP(TM) 15mm rotatable mechanical heart valve and the Amplatzer Piccolo(TM) Occluder have received CE Mark and are now available in... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  Abbott GmbH & Co. KG

Ozempic® Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza® and Canagliflozin in People With Type 2 Diabetes

BAGSVÆRD, Denmark, Sept. 17, 2019 /PRNewswire/ -- Novo Nordisk announced today the results from two Ozempic(® )(once-weekly semaglutide 1.0 mg) head-to-head Phase 3 clinical trials, SUSTAIN 8 and SUSTAIN 10, which showed:

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2019

ViVitro Labs Acquires ProtomedLabs

Merger strengthens European service and expands cardiovascular customization capabilities

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2019

Oral semaglutide improves glycaemic control in people with type 2 diabetes across baseline blood glucose levels

BARCELONA, Spain, Sept. 17, 2019 /PRNewswire/ -- Novo Nordisk today announced findings from an exploratory analysis of the PIONEER trial programme, showing oral semaglutide (3, 7 and 14 mg) improved glycaemic control in people with type 2 diabetes across baseline HbA(1c) levels. Greater reductions... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019

Owen Mumford Launches Next Generation Safety Needle

OXFORD, England, Sept. 17, 2019 /PRNewswire/ -- Owen Mumford, a global leader in designing and manufacturing innovative medical devices, has announced it is launching Ateria(®) SafeControl(®) the next generation of safety pen needles. The new and innovative device will be previewed at the 55(th)... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  Owen Mumford Ltd

Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer

HERTFORDSHIRE, England and PITTSBURGH, Sept. 17, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Fulvestrant... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019

MyMeds&Me Launches Enhanced Mobile Version of Their Public Drug Safety Reporting Solution - "Reportum Public"

Coinciding with World Patient Safety Day, the latest version provides patients and healthcare professionals with a secure mobile-web solution to report adverse events globally

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  MyMeds&Me Ltd

IBH Expands Leadership Team to Support its Expansion as a National Healthcare, Analytics & Technology Provider

COSTA MESA, Calif., Sept. 17, 2019 /PRNewswire/ -- IBH Population Health Solutions (Integrated Behavioral Health, Inc.) announced today that three industry veterans have joined its senior leadership team.

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2019

PhRMA Names Lori Reilly Chief Operating Officer

WASHINGTON, Sept. 17, 2019 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) today named Lori M. Reilly, Esq. as chief operating officer (COO), a new position within PhRMA. Reilly has been at PhRMA for nearly 20 years, most recently serving as executive vice president... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  Pharmaceutical Research and Manufacturers of America (PhRMA)

FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma

SILVER SPRING, Md., Sept. 17, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration is announcing Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  U.S. Food and Drug Administration

Senzer's Medical Device Approved in Europe for the Safe and Effective Delivery of Cannabinoids

LONDON, Sept. 17, 2019 /PRNewswire/ -- Senzer Pharmaceuticals has been granted a CE Mark that certifies its inhaler as a medical device, allowing it to now be available for patients in Europe for the 'safe and effective delivery of pharmaceutical cannabinoids.'

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2019

Dr. Jeffrey Cummings Wins Alzheimer's Drug Discovery Foundation's (ADDF) Prestigious Melvin R. Goodes Prize

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Dr. Jeffrey Cummings, a world-renowned Alzheimer's researcher and leader in clinical trials, has been named the recipient of the 2019 Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  Alzheimer's Drug Discovery Foundation

Cortland Biomedical Launches with State-of-the-Art Facility for Design, Development and Manufacturing of Custom Textile Structures for the Medical Device Industry

CORTLAND, N.Y., Sept. 17, 2019 /PRNewswire/ -- Cortland Biomedical, a full-service medical textiles product development partner that provides access to a spectrum of engineering, design and manufacturing capabilities, has unveiled a new, purpose-built manufacturing facility strategically designed... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019

Jonathan C. Reiter Reports - Why Are Medical Malpractice Cases Hard to Win?

DALLAS, Sept. 17, 2019 /PRNewswire/ -- Medical malpractice cases are more difficult to win because patients may feel intimidated by the process. If you have been injured by a doctor's or hospital's negligence, it's important to discuss your case with the most experienced medical malpractice lawyer.

... Read more ››
By: PR Newswire Association LLC. - 17 Sep 2019

MBio Diagnostics Announces Two Contracts for Algae Toxin Test Development

BOULDER, Colo., Sept. 17, 2019 /PRNewswire/ -- MBio Diagnostics, Inc., today announced two contracts to develop new tests for algae toxins. These tests will expand the offerings available on MBio's existing platform, the Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  MBio Diagnostics, Inc.

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved

SEATTLE and COLUMBIA, Md., Sept. 17, 2019 /PRNewswire/ -- Welldoc, a leader in digital health, today announced activation results for Welldoc's... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
Related companies:  WellDoc, Inc. | Xealth Inc.

Parkinson's Foundation Invests $4.2 Million in Research Grants

MIAMI and NEW YORK, Sept. 17, 2019 /PRNewswire/ -- The Parkinson's Foundation today announced an investment of $4.2 million across... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019

Medical Database Study on Improved Test Utilization Using LDS®, a Proprietary Laboratory Decision System, Published in the Journal of Clinical and Laboratory Medicine

IRVINE, Calif., Sept. 17, 2019 /PRNewswire/ -- Medical Database, Inc., a leader in providing updated medical information to healthcare providers, insurance companies and educational institutions, today announced the publication of a clinical study which provides evidence for the effectiveness... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019

Enteral Feeding Devices (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes) Market - Global Forecast to 2024

DUBLIN, Sept. 17, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019

US Nephrologists Beginning to Trial AstraZeneca's LOKELMA (zirconium sodium cyclosilicate) but Unclear on Differentiation from Vifor/Relypsa's VELTASSA (patiromer FOS)

EXTON, Pa., Sept. 17, 2019 /PRNewswire/ -- After two Complete Response Letters resulting in lengthy approval delays, AstraZeneca was finally able to introduce Lokelma, its novel treatment for hyperkalemia, to the US market earlier this year. Lokelma was acquired from ZS Pharma in 2015 for $2.7... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2019
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑